Deal activity by volume related to cybersecurity increased by 64% year-on-year in 2022 in the medical device industry

Analysis of the key themes driving deal activity reveals that cybersecurity accounted for 58 medical device deals between 2018 and 2022, worth a total value of $1,918m, according to GlobalData’s Deals database covering mergers and acquisitions, private equity, venture financing, equity offerings and partnerships. The $75m venture financing of RapidSOS was the largest disclosed deal in 2022, while the $1,546m equity offering by Lenovo Group was the largest disclosed deal in 2021.  

In volume terms, cybersecurity related deal activity increased by 64% year-on-year in 2022 and remained flat year-on-year in 2021. 

Partnerships accounted for the highest number of deals in the last five years, with 24 deals, followed by venture financing (16 deals), and acquisitions (7 deals).

The top legal advisors supporting deals related to cybersecurity in the medical device industry in the last five years in terms of value were Willkie Farr & Gallagher; Wilson Sonsini Goodrich & Rosati Professional; DLA Piper; Latham & Watkins; and Evergreen Legal.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s Deals database provides comprehensive coverage across industries tracking market activity of global mergers & acquisitions, including asset acquisitions/divestments; private equity deals (PE); venture finance deals (VC); equity offerings, including IPOs, follow-on offerings, and private placements; debt offerings, including private placements, ESG bonds and loans; partnerships; and licensing agreements. 

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumored deals.